BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 1381766)

  • 1. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure.
    Moe GW; Forster C; de Bold AJ; Armstrong PW
    Clin Invest Med; 1990 Jun; 13(3):111-8. PubMed ID: 2142031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F; Guardigli G; Cappelli M; Bernardi P
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M; Tritto C; De Luca N; Mele AF; Lembo G; Rubattu S; Romano M; De Campora P; Enea I; Ricciardelli B
    J Clin Invest; 1991 Nov; 88(5):1481-9. PubMed ID: 1834698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR; Thibault G; Kuchel O; Hamet P; Cantin M; Larochelle P
    J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of naloxone on plasma levels of atrial natriuretic factor and noradrenaline during water load in moderate heart failure].
    Tarsi G; Paradossi U; Tartuferi L; Schipani A; Palmisano D; De Iasio R; Carboni L; Fontana F; Bernardi P
    G Ital Cardiol; 1996 Aug; 26(8):879-85. PubMed ID: 9005170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T; Heim JM; Weil J; Wehling M; Witzgall H; Gerzer R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological effects of synthetic atrial natriuretic factor in normal conscious dogs.
    Moe GW; Forster C; de Bold AJ; Armstrong PW
    Clin Invest Med; 1988 Dec; 11(6):417-24. PubMed ID: 2976333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of hemodynamic and renal effects of i.v. alpha-hANF (99-126) in conscious calves.
    Windberger U; Vierhapper H; Osterode W; Nowotny P; Losert U
    Horm Metab Res; 1993 May; 25(5):259-63. PubMed ID: 8330860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.